They have more news in the pipeline which should be released very soon. In the CEO's words: "We are seeing great results and we look forward to presenting these results over the course of the next few weeks."
On watch:
EGLT, now in the mid 6's, awaiting FDA update on their PDUFA VCEL: following the bio trend down but PDUFA on 3 Jan
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.